NYSE:PRGO - Perrigo Stock Price, News, & Analysis

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Perrigo announced a quarterly dividend on Wednesday, October 31st. Stockholders of record on Friday, November 30th will be paid a dividend of $0.19 per share on Tuesday, December 18th. This represents a $0.76 annualized dividend and a dividend yield of 1.69%. The ex-dividend date of this dividend is Thursday, November 29th. View Perrigo's Dividend History.

Perrigo Company PLC (NYSE:PRGO) announced its quarterly earnings data on Thursday, November, 8th. The company reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.04. The company earned $1.13 billion during the quarter, compared to analysts' expectations of $1.17 billion. Perrigo had a return on equity of 11.32% and a net margin of 2.54%. Perrigo's revenue for the quarter was down 8.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.39 EPS. View Perrigo's Earnings History.

Perrigo is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for Perrigo.

Perrigo updated its FY18 earnings guidance on Thursday, November, 8th. The company provided EPS guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS.

13 brokerages have issued 12-month price objectives for Perrigo's shares. Their predictions range from $46.00 to $110.00. On average, they expect Perrigo's share price to reach $77.3571 in the next twelve months. This suggests a possible upside of 72.1% from the stock's current price. View Analyst Price Targets for Perrigo.

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 1 sell rating, 10 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Perrigo.

News stories about PRGO stock have been trending positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Perrigo earned a media sentiment score of 2.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 7.0 out of 10, indicating that recent news coverage is likely to have an impact on the company's share price in the next few days.

Perrigo saw a decrease in short interest in the month of December. As of December 31st, there was short interest totalling 5,474,515 shares, a decrease of 37.7% from the December 14th total of 8,791,586 shares. Based on an average trading volume of 3,537,573 shares, the days-to-cover ratio is currently 1.5 days. Currently, 4.0% of the company's shares are short sold. View Perrigo's Current Options Chain.

Some companies that are related to Perrigo include Alexion Pharmaceuticals (ALXN), Shiseido (SSDOY), Teva Pharmaceutical Industries (TEVA), UCB (UCBJF), BioMarin Pharmaceutical (BMRN), Mylan (MYL), Ono Pharmaceutical (OPHLF), Merck KGaA (MKGAF), GRIFOLS S A/S (GRFS), Genmab A/S (GNMSF), Alnylam Pharmaceuticals (ALNY), Beigene (BGNE), Sarepta Therapeutics (SRPT), Bausch Health Companies (BHC) and Ionis Pharmaceuticals (IONS).

Perrigo's stock is owned by a number of of retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.03%), Moon Capital Management LLC (0.02%) and Louisiana State Employees Retirement System (0.00%). Company insiders that own Perrigo stock include Geoffrey M Parker, Jeffrey C Smith, Jeffrey Needham, John Wesolowski, Murray S Kessler, Sharon Kochan, Svend Andersen, Thomas Farrington, Todd W Kingma and Uwe Roehrhoff. View Institutional Ownership Trends for Perrigo.

PRGO stock was sold by a variety of institutional investors in the last quarter, including Moon Capital Management LLC and Louisiana State Employees Retirement System. View Insider Buying and Selling for Perrigo.

PRGO stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have bought Perrigo stock in the last two years include Geoffrey M Parker, Jeffrey C Smith, John Wesolowski, Murray S Kessler, Svend Andersen, Todd W Kingma and Uwe Roehrhoff. View Insider Buying and Selling for Perrigo.

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of PRGO stock can currently be purchased for approximately $44.96.

Perrigo has a market capitalization of $6.21 billion and generates $4.95 billion in revenue each year. The company earns $119.60 million in net income (profit) each year or $4.93 on an earnings per share basis. Perrigo employs 10,400 workers across the globe.

The official website for Perrigo is http://www.perrigo.com.

Perrigo's mailing address is TREASURY BUILDING LOWER GRAND CANAL STREET, DUBLIN L2, 49010. The company can be reached via phone at 353-1709-4000 or via email at [email protected]